Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
V. Craig Jordan, a pharmacologist whose discovery {that a} failed contraceptive, tamoxifen, might block the expansion of breast most cancers cells opened up...
A brand new imaging approach developed at Memorial Sloan Kettering Most cancers Middle (MSK) exhibits promise for detecting lethal types of lung most...
